Abeona Therapeutics (ABEO)

• Market cap: $271M
• 1 day: -1.19%
• 5 days: 0.2%
• 1 month: -1.96%
• 3 months: 1.21%
• 6 months: -21.63%
• Year to date: -5.84%
• 1 year: -16.67%
• 5 years: -93.24%
• 10 years: -91.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Employees: 136